Crescent Biopharma (CBIO) Tax Rate (2014)

Crescent Biopharma (CBIO) posted quarterly Tax Rate of 1.15% for Q3 2014, up 20.53% quarter-over-quarter from 0.95% in Q2 2014.

Crescent Biopharma (CBIO) Tax Rate (2014) Analysis & Trends

Crescent Biopharma (CBIO) has reported Tax Rate for 1 consecutive years, with 1.15% the latest figure, recorded in Q3 2014.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Tax Rate (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn	20.98%
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn	15.11%
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn	10.91%
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn	-1.96%
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn	24.15%
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn	7.49%
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn	-16.71%
8	Royalty Pharma	26.98 Bn	26.14 Bn	-	-
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn	34.12%
10	Crescent Biopharma	1.05 Bn	875.92 Mn	-	-

Download Data